Single Founder Mutation (W380G) in Type II Protein C Deficiency in Finland

Summary

The present study investigated the genetic basis for type II protein C deficiency in Finland, where this form has an unusually high incidence. We demonstrated that, first, a single novel mutation W380G in the protein C gene (PROC) explained 25/26 index patients, estimated to represent two thirds of all families with type II deficiency in Finland. Second, extended chromosomal conservation, i. e. a specific haplotype, around the W380G mutation was indicated in unrelated patients. Third, a local geographical origin for the W380G mutation was suggested by genealogical data. These results are in contrast to the heterogeneity in type II protein C deficiency elsewhere, but closely parallel disorders of the Finnish disease heritage. The high frequency of the type II disease can be explained by founder effect and subsequent enrichment of a single mutation in Finland. The present study also provided a simple means for genetic diagnosis of this disease and the genetic test can be included in the routine screenings in this population.

Key words

Protein C - thrombosis - genetic disorders - Finnish population - mutation - PROC gene

^* Present address: Laboratory of Forensic Biology, Department of Forensic Medicine, University of Helsinki, Helsinki, Finland

• References

• 1 Aiach M, Borgel D, Gaussem P, Emmerich J, Alhenc-Gelas M, Gandrille S. Protein C and protein S deficiencies. Semin Hematol 1997; 34: 205-17.
• 2 Reitsma PH. Protein C deficiency: from gene defects to disease. Thromb Haemost 1997; 78: 344-50.
• 3 Krawczak M, Cooper DN. The human gene mutation database. Trends Genet 1997; 13: 121-2.
• 4 Nevanlinna HR. The Finnish population structure A genetic and genealogical study. Hereditas 1972; 71: 195-236.
• 5 de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 1993; 30: 857-65.
• 6 Peltonen L, Pekkarinen P, Aaltonen J. Messages from an isolate: lessons from the Finnish gene pool. Biol Chem 1995; 376: 697-704.
• 7 Zhong N, Kajanoja E, Smits B, Pietrofesa J, Curley D, Wang D, Ju W, Nolin S, Dobkin C, Ryynänen M, Brown WT. Fragile X founder effects and new mutations in Finland. Am J Med Genet 1996; 64: 226-33.
• 8 Vuorio A. A molecular and clinical study of heterozygous familial hypercholesterolemia in the Finnish North Karelia. Thesis, University of Helsinki, Finland. 1998 63.
• 9 Levo A, Jääskeläinen J, Sistonen P, Sirén M-K, Voutilainen R, Partanen J. Tracing past population migrations: genealogy of steroid 21hydroxylase (CYP21) gene mutations in Finland. Eur J Hum Genet 1999; 07: 188-96.
• 10 Reitsma PH, Poort SR, Allaart CF, Briët E, Bertina RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency Type I: heterogeneity and founder effects. Blood 1991; 78: 890-94.
• 11 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-7.
• 12 Spek CA, Poort SR, Bertina RM, Reitsma PH. Determination of the allelic and haplotype frequencies of three polymorphisms in the promoter region of the human protein C gene. Blood Coagul Fibrinolysis 1994; 05: 309-11.
• 13 Reitsma PH, te Lintel WHekkert, Koenhen E, van der Velden PA, Allaart CF, Deutz-Terlouw PP, Poort SR, Bertina RM. Application of two neutral Msp I DNA polymorphisms in the analysis of hereditary protein C deficiency. Thromb Haemost 1990; 64: 239-44.
• 14 Schneider S, Kueffer J-M, Roessli D, Excoffier F. Arlequin ver. 1.1: A software for population genetic data analysis. Genetics and Biometry Laboratory. University of Geneva, Switzerland: 1997
• 15 Couture P, Demers C, Morisette J, Delage R, Jomphe M, Couture L, Simard J. Type I protein C deficiency in French Canadians: evidence of a founder effect and association of specific protein C gene mutations with plasma protein C levels. Thromb Haemost 1998; 80: 551-6.
• 16 Poort SR, Pabinger-Fasching I, Mannhalter C, Reitsma PH, Bertina RM. Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency. Blood Coagul Fibrinolysis 1993; 04: 273-80.
• 17 Koster T, Rosendaal FR, Briët E, van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden thrombophilia study). Blood 1995; 85: 2756-61.
• 18 Miyata T, Sakata T, Zheng Y-Z, Tsukamoto H, Umeyama H, Uchiyama S, Ikusaka M, Yoshioka A, Imanaka Y, Fujimura H, Kambayashi J-i, Kato H. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-strand conformational polymorphism analysis and a model building. Thromb Haemost 1996; 76: 302-11.